论文部分内容阅读
中华医学会神经病学分会和赛诺菲-安万特联合推出今年的中国卒中教育日(11月20日)主题是“早防早治,远离复发”。专家指出:中国脑卒中(俗称“中风”)的发病率越来越高,首发脑卒中后的复发率也仍居高不下。WHO的报告显示,脑卒中是世界范围内第三位死亡原因,中国是脑卒中高发国家。每年新发脑卒中病例约250万例,平均每12秒就有1人发生卒中。脑卒中可分为两种类型:缺血性脑卒中和出血性脑卒中,其中缺血性脑卒中占大部分。缺血性脑卒中是动脉粥样硬化血栓形成性疾病的一个重要临床表现。有过卒中史,或伴有多种危险因素/多血管床病变患者等都处于卒中复发的高风险中。同时,还需警惕脑卒中的“先兆”——小中风(短暂性缺血性发作)。早防早治是防止脑卒中复发的关键。在卒中高危人群的自我评估中发现,针对缺血性卒中的预防,强化抗血小板治疗,是预防卒中复发的重中之重。
Chinese Medical Association neurology branch and sanofi-aventis jointly launched this year’s China Stroke Education Day (November 20) theme is “early prevention and early treatment, away from recurrence.” Experts point out that the incidence of stroke in China (commonly known as “stroke”) is getting higher and higher, the recurrence rate after the first stroke is still high. WHO’s report shows that stroke is the third leading cause of death in the world and that China is a country with a high incidence of stroke. About 2.5 million new stroke cases occur each year, with an average of one stroke occurring every 12 seconds. Stroke can be divided into two types: ischemic stroke and hemorrhagic stroke, of which ischemic stroke accounts for the majority. Ischemic stroke is an important clinical manifestation of atherothrombosis. Have had a history of stroke, or with a variety of risk factors / patients with multiple vascular lesions are at high risk of stroke recurrence. At the same time, vigilance is needed to be aware of the “aura” of stroke - a small stroke (transient ischemic attack). Early prevention and early treatment is the key to prevent the recurrence of stroke. In the self-assessment of high-risk stroke population found that the prevention of ischemic stroke, intensive anti-platelet therapy is to prevent the recurrence of stroke is the top priority.